![]() Providing access to and encouraging the use of effective cessation interventions greatly increases the likelihood of successfully quitting tobacco. Today’s tobacco users will make up the majority of future tobacco-related deaths, which will disproportionately affect LMICs ( Yach et al., 2014). Thus, it is important not only to stress the importance of quitting smoking, but the importance of doing so at a young age ( Jha et al., 2013). Smokers who quit before the age of 45 will shed most of the excess risk of smoking and gain on average 9–10 years of life, whereas those who quit later will lose about half of their excess risk from smoking, gaining 4–6 years of life expectancy (Box 1). Quitting smoking can reverse the excess risk borne by smokers, and the lower the age at quitting, the greater is the degree of excess risk that is lost. The principle of tobacco harm reduction, where adult smokers eventually completely switch to non-combustible nicotine-containing products, can be applied to achieve and maintain cessation (adapted from ASH UK). Nicotine is the addictive element of tobacco, but it is the tar and other toxicants in tobacco smoke, not nicotine, that cause most of the harm. ![]() “Smoking cessation” or “quitting smoking” is to completely stop smoking combustible cigarettes. Smoking-related diseases include heart disease, chronic obstructive pulmonary disease and cancer. Smoking is a leading cause of preventable death and disease globally. The full terms of this licence may be seen at: ![]() Anyone may reproduce, distribute, translate and create derivative works of this article (for both commercial and non-commercial purposes), subject to full attribution to the original publication and authors. This article is published under the Creative Commons Attribution (CC BY 4.0) licence. Ĭopyright © 2020, Sudhanshu Patwardhan and Jed E. (2020), "Overcoming barriers to disseminate effective smoking cessation treatments globally", Drugs and Alcohol Today, Vol. Also, widely prevalent smartphone devices may deliver smoking cessation through telemedicine in LMICs sooner, leapfrogging the hurdles of the existing health-care infrastructure. Additionally, HCPs can play an important role in offering smoking cessation support in existing national health programmes for TB, cancer screening and maternal and child health. In low- and middle-income countries (LMICs), HCPs’ knowledge, attitudes and practice regarding tobacco use and cessation may hold the key to rapidly scaling up cessation support and delivery to achieve FCTC objectives sooner. Innovation is urgently needed to fill the gaps in smoking cessation products and services, and for converting global policy into local practice. ![]() E-cigarettes are sophisticated nicotine replacement products. Smoking cessation is a desirable health outcome and nicotine replacement products are a means of achieving cessation through tobacco harm reduction. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |